Sarcoma Patient Registry
The Sarcoma Foundation of America has been in the process of developing a Sarcoma Patient Registry over the last 18 months. Here is the history, the process, and the purpose of the Registry.
It is a national effort to get a united Sarcoma Patient Registry to help in the quest for a Cure in Our Time!
HISTORY AND PROCESS
We have contracted with a company called Registry Partners to help facilitate the implementation and population of the Patient Registry. The initial step was to get an overview of the incidence and geographic data for 5 specific sarcoma subtypes. The information compiled gave a very clear representation of the actual number and location of sarcoma patients in the continental US.. In January of 08, the SFA started beta testing the next evolution of the Registry by actually allowing patients to submit their data to the registry . Initially, we reached out to sarcoma patients with the 5 specific subtypes but now have expanded the scope of the Registry to include information for all subtypes of sarcoma.
The process of enrollment in the Registry is that patients are either informed by their doctor about the Registry in the form of an introductory packet or brochure, or they reach out to the Registry by way of an e-mail through a link on the Foundationís Registry page. The patient is then contacted by the SFA Registry staff. The initial contact is to obtain general demographic and tumor data and then the case is suspended pending the receipt of the supporting medical records by the Registry. The patient is sent a packet that contains an introductory letter about the Registry, a Registry Brochure, a Registration Form, and a Medical Release Form. The Medical Release Form and Registration forms are then sent back to the Registry staff for processing. The Registry then contacts the patientís doctors to request copies of the patientís medical records, which has been authorized by the patient. By reviewing the requested medical records, the trained registry staff will then enter the data into the Registry to complete the cancer case. This process will allow for the most complete and accurate data to be included in the Registry. The Registry staff will then do a follow up every 6 months in order to monitor the patientís progress and update any new diagnoses or treatment information in the registry.
Due to the fractured nature of the US healthcare system, there is currently no universal database that provides access to information on sarcoma patients. This makes it challenging for public or private researchers to gather enough data to fully study genetic pathways and identify therapeutic candidates for all but the most common sarcoma sub-types. The SFA hopes to help address this issue by creating a comprehensive Sarcoma Patient Registry that will track the progress of patients with all forms of sarcoma.
The current goal of the Registry is to gather new data from patients that have a current diagnosis and future patients as identified by physicians and organizations that have already joined with us in this effort. The Sarcoma Patient Registry is designed to be a powerful source of information for scientists on the hunt for markers, genetic pathways and effective therapies for sarcomas. When patients enroll in the Registry, they also have the option on the consent form of being notified about current or future clinical trials for their specific subtype. Registry staff can then inform patients about possible clinical trials. Trial accrual is an important factor in finding new weapons to treat sarcoma. Accrual is a struggle for all cancer types and an even more critical issue when focusing on a rare cancer and an even rarer subtype. Patient contact and identifying information is ALWAYS kept confidential.
Eventually the goal of the Registry will be to become a repository of data for all sarcoma patients, capturing information on individual patient diagnosis, treatment and outcomes. The overarching future goal is for all sarcoma patients to be entered in one national database and to be a virtual historical control group that replaces/augments the need for control cells in clinical trials on sarcomas, and thereby encouraging increased interest in pursuing these costly trials with low accrual rates. I know in time we can do this!
Letís find a cure together!
Sarcoma Foundation of America
Please click here for more information about the Sarcoma Patient Registry.
To register, you can send an email to email@example.com
or call toll free (866) 501-6780.
Last Edited -
19 June 2009 15:28 pm